Scientists Urge FDA To Assess T-Cell Levels In COVID-19 Vaccine Analysis

More than 60 members of the scientific community, including current and former HHS officials, say FDA should push COVID-19 makers to assess the level of T-cells produced by COVID-19 vaccines in clinical trials instead of just looking at antibodies, which they say would help policy makers better evaluate the efficacy of the shots and protect against severe disease and death. In a letter sent to the agency Thursday (April 21), the experts say that measuring both the amount of T-cells...
Article Type: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 04/29/2022
FDA Volume: 
Vol. 28, No. 17
Author: 




FDA Aims To Study How Rx Drug Promo Affects Patient, Physician Choices

FDA hopes to conduct a study assessing how prescription drug promotion, and in particular information about a drug’s efficacy, risks and adherence, affects medication decisions by consumers and providers, the agency announced Friday (April 22). The proposed study will focus on medications for type 2 diabetes and psoriasis. There is currently little information on the tradeoffs patients make when considering drug product characteristics and how the tradeoffs could potentially differ from the tradeoffs made by physicians, FDA says in its...
Article Type: 
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 04/25/2022
IDP Volume: 
Vol. 5, No. 17
Author: 








Hospitals: Proposed Inpatient Fiscal 2023 Pay Drop Unacceptable

Hospital officials are upset that, when taken in its entirety, the proposed inpatient pay rule would amount to a pay cut -- and they say even the pay update pales in comparison to overall inflation. Fiscal 2023 is not the time to cut back on pay that helps hospitals cover the cost of uncompensated care and caring for the uninsured during the pandemic, they assert. CMS’ fiscal 2023 hospital inpatient proposed rule includes a 3.2% rate increase for inpatient prospective...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 04/28/2022
CMS Volume: 
Vol. 25, No. 17
Author: 

Over One In Four Long Term Care Facilities Report Workforce Shortages

Long term care workforce shortages have intensified significantly as a result of the COVID-19 pandemic, according to a new report, which finds that nearly of a quarter of facilities nationwide have reported shortages in nursing staff since the start of 2022. The new report, which consumer group Seniorly conducted using CMS nursing home staffing data from 2020-2022, found the number of facilities that experienced a worker shortage rose from 11% in May 2020 to as high as 23% in January...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 04/28/2022
CMS Volume: 
Vol. 25, No. 17
Author: 

Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.